The First Experience of Effective 3rd Line Antiretroviral Therapy – A Case of 40-Year-Old Female Retroviral-Infected Patient at Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia

BACKGROUND: Treatment failure continues to be an impediment to the efficacy of highly active antiretroviral therapy (HART) in the treatment of human immunodeficiency virus type 1 infection (HIV-1). The World Health Organization (WHO) recommends third-line antiretroviral therapy (ART) for patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketema, Worku, Taye, Kefyalew, Shibeshi, Mulugeta Sitot, Tagesse, Negash, Hirigo, Agete Tadewos, Woubishet, Kindie, Gutema, Selamawit, Eifa, Aberash, Toma, Alemayehu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631462/
https://www.ncbi.nlm.nih.gov/pubmed/34858075
http://dx.doi.org/10.2147/RRTM.S341711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631462/
https://www.ncbi.nlm.nih.gov/pubmed/34858075
http://dx.doi.org/10.2147/RRTM.S341711

Ejemplares similares